FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3104558320> ?p ?o ?g. }

• W3104558320 abstract "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB)3-mediated glycolysis is pivotal in driving macrophage- and endothelial cell activation and thereby inflammation. Once activated, these cells play a crucial role in the progression of atherosclerosis. Here, we analyzed the expression of PFKFB3 in human atherosclerotic lesions and investigated the therapeutic potential of pharmacological inhibition of PFKFB3 in experimental atherosclerosis by using the glycolytic inhibitor PFK158.PFKFB3 expression was higher in vulnerable human atheromatous carotid plaques when compared to stable fibrous plaques and predominantly expressed in plaque macrophages and endothelial cells. Analysis of advanced plaques of human coronary arteries revealed a positive correlation of PFKFB3 expression with necrotic core area. To further investigate the role of PFKFB3 in atherosclerotic disease progression, we treated 6-8 weeks old male Ldlr-/- mice. These mice were fed a high cholesterol diet for 13 weeks, of which they were treated for 5 weeks with the glycolytic inhibitor PFK158 to block PFKFB3 activity. The incidence of fibrous cap atheroma (advanced plaques) was reduced in PFK158-treated mice. Plaque phenotype altered markedly as both necrotic core area and intraplaque apoptosis decreased. This coincided with thickening of the fibrous cap and increased plaque stability after PFK158 treatment. Concomitantly, we observed a decrease in glycolysis in peripheral blood mononuclear cells compared to the untreated group, which alludes that changes in the intracellular metabolism of monocyte and macrophages is advantageous for plaque stabilization.High PFKFB3 expression is associated with vulnerable atheromatous human carotid and coronary plaques. In mice, high PFKFB3 expression is also associated with a vulnerable plaque phenotype, whereas inhibition of PFKFB3 activity leads to plaque stabilization. This data implies that inhibition of inducible glycolysis may reduce inflammation, which has the ability to subsequently attenuate atherogenesis." @default.
• W3104558320 created "2020-11-23" @default.
• W3104558320 creator A5008600630 @default.
• W3104558320 creator A5014721757 @default.
• W3104558320 creator A5036092220 @default.
• W3104558320 creator A5047373721 @default.
• W3104558320 creator A5058842094 @default.
• W3104558320 creator A5065971022 @default.
• W3104558320 creator A5069173292 @default.
• W3104558320 creator A5074605031 @default.
• W3104558320 creator A5080200084 @default.
• W3104558320 creator A5081411192 @default.
• W3104558320 creator A5081557648 @default.
• W3104558320 date "2020-11-12" @default.
• W3104558320 modified "2023-10-13" @default.
• W3104558320 title "Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability" @default.
• W3104558320 cites W1964064254 @default.
• W3104558320 cites W1990253071 @default.
• W3104558320 cites W2010239439 @default.
• W3104558320 cites W2051236743 @default.
• W3104558320 cites W2054990827 @default.
• W3104558320 cites W2079724669 @default.
• W3104558320 cites W2083416749 @default.
• W3104558320 cites W2087175050 @default.
• W3104558320 cites W2102311561 @default.
• W3104558320 cites W2106470271 @default.
• W3104558320 cites W2124008781 @default.
• W3104558320 cites W2128368961 @default.
• W3104558320 cites W2156593520 @default.
• W3104558320 cites W2161682643 @default.
• W3104558320 cites W2276012049 @default.
• W3104558320 cites W2285780972 @default.
• W3104558320 cites W2342101280 @default.
• W3104558320 cites W2533310720 @default.
• W3104558320 cites W2556868315 @default.
• W3104558320 cites W2563816277 @default.
• W3104558320 cites W2764031540 @default.
• W3104558320 cites W2782649526 @default.
• W3104558320 cites W2789459269 @default.
• W3104558320 cites W2789588679 @default.
• W3104558320 cites W2791004319 @default.
• W3104558320 cites W2791927056 @default.
• W3104558320 cites W2794080343 @default.
• W3104558320 cites W2883700159 @default.
• W3104558320 cites W2895410450 @default.
• W3104558320 cites W2904421322 @default.
• W3104558320 cites W2905181093 @default.
• W3104558320 cites W3011515401 @default.
• W3104558320 cites W3082667714 @default.
• W3104558320 cites W839604547 @default.
• W3104558320 doi "https://doi.org/10.3389/fcell.2020.581641" @default.
• W3104558320 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7688893" @default.
• W3104558320 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33282864" @default.
• W3104558320 hasPublicationYear "2020" @default.
• W3104558320 type Work @default.
• W3104558320 sameAs 3104558320 @default.
• W3104558320 citedByCount "29" @default.
• W3104558320 countsByYear W31045583202021 @default.
• W3104558320 countsByYear W31045583202022 @default.
• W3104558320 countsByYear W31045583202023 @default.
• W3104558320 crossrefType "journal-article" @default.
• W3104558320 hasAuthorship W3104558320A5008600630 @default.
• W3104558320 hasAuthorship W3104558320A5014721757 @default.
• W3104558320 hasAuthorship W3104558320A5036092220 @default.
• W3104558320 hasAuthorship W3104558320A5047373721 @default.
• W3104558320 hasAuthorship W3104558320A5058842094 @default.
• W3104558320 hasAuthorship W3104558320A5065971022 @default.
• W3104558320 hasAuthorship W3104558320A5069173292 @default.
• W3104558320 hasAuthorship W3104558320A5074605031 @default.
• W3104558320 hasAuthorship W3104558320A5080200084 @default.
• W3104558320 hasAuthorship W3104558320A5081411192 @default.
• W3104558320 hasAuthorship W3104558320A5081557648 @default.
• W3104558320 hasBestOaLocation W31045583201 @default.
• W3104558320 hasConcept C126322002 @default.
• W3104558320 hasConcept C134018914 @default.
• W3104558320 hasConcept C142724271 @default.
• W3104558320 hasConcept C190283241 @default.
• W3104558320 hasConcept C20251656 @default.
• W3104558320 hasConcept C202751555 @default.
• W3104558320 hasConcept C203014093 @default.
• W3104558320 hasConcept C2776914184 @default.
• W3104558320 hasConcept C2779179121 @default.
• W3104558320 hasConcept C2779244956 @default.
• W3104558320 hasConcept C2779318932 @default.
• W3104558320 hasConcept C2781184567 @default.
• W3104558320 hasConcept C502942594 @default.
• W3104558320 hasConcept C55493867 @default.
• W3104558320 hasConcept C62231903 @default.
• W3104558320 hasConcept C71924100 @default.
• W3104558320 hasConcept C86803240 @default.
• W3104558320 hasConceptScore W3104558320C126322002 @default.
• W3104558320 hasConceptScore W3104558320C134018914 @default.
• W3104558320 hasConceptScore W3104558320C142724271 @default.
• W3104558320 hasConceptScore W3104558320C190283241 @default.
• W3104558320 hasConceptScore W3104558320C20251656 @default.
• W3104558320 hasConceptScore W3104558320C202751555 @default.
• W3104558320 hasConceptScore W3104558320C203014093 @default.
• W3104558320 hasConceptScore W3104558320C2776914184 @default.
• W3104558320 hasConceptScore W3104558320C2779179121 @default.
• W3104558320 hasConceptScore W3104558320C2779244956 @default.

• next